Akero Therapeutics (AKRO) Tops Q2 EPS by 2c
Akero Therapeutics (NASDAQ: AKRO) reported Q2 EPS of ($0.81), $0.02 better than the analyst estimate of ($0.83).
For earnings history and earnings-related data on Akero Therapeutics (AKRO) click here.
Akero Therapeutics (NASDAQ: AKRO) reported Q2 EPS of ($0.81), $0.02 better than the analyst estimate of ($0.83).
For earnings history and earnings-related data on Akero Therapeutics (AKRO) click here.